Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COMMON STOCK-FO
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
49.1M
-
Shares change
-
+453K
-
Total reported value, excl. options
-
$577M
-
Value change
-
+$4.17M
-
Number of buys
-
27
-
Number of sells
-
-19
-
Price
-
$11.74
Significant Holders of MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) as of Q1 2017
56 filings reported holding MYOV - MYOVANT SCIENCES LTD - COMMON STOCK-FO as of Q1 2017.
MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.1M shares
.
Largest 10 shareholders include QVT Financial LP (37.2M shares), BB BIOTECH AG (3.3M shares), RA CAPITAL MANAGEMENT, LLC (2.35M shares), BlackRock Inc. (1.37M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (750K shares), DEERFIELD MANAGEMENT CO (705K shares), NORGES BANK (622K shares), GREAT POINT PARTNERS LLC (408K shares), Tekla Capital Management LLC (400K shares), and Voya Investment Management LLC (400K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.